Helius Medical Technologies (NASDAQ:HSDT – Get Free Report) and Sensus Healthcare (NASDAQ:SRTS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.
Risk & Volatility
Helius Medical Technologies has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500.
Profitability
This table compares Helius Medical Technologies and Sensus Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Helius Medical Technologies | -3,010.14% | -418.82% | -243.54% |
| Sensus Healthcare | 4.56% | 3.34% | 3.00% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Helius Medical Technologies | 0 | 1 | 0 | 0 | 2.00 |
| Sensus Healthcare | 0 | 0 | 3 | 0 | 3.00 |
Sensus Healthcare has a consensus price target of $11.67, suggesting a potential upside of 170.06%. Given Sensus Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than Helius Medical Technologies.
Institutional and Insider Ownership
18.6% of Helius Medical Technologies shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 17.9% of Helius Medical Technologies shares are owned by insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Helius Medical Technologies and Sensus Healthcare”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Helius Medical Technologies | $520,000.00 | 0.14 | -$11.74 million | ($2,376.32) | 0.00 |
| Sensus Healthcare | $41.81 million | 1.70 | $6.65 million | $0.10 | 43.20 |
Sensus Healthcare has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Summary
Sensus Healthcare beats Helius Medical Technologies on 13 of the 14 factors compared between the two stocks.
About Helius Medical Technologies
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
About Sensus Healthcare
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
